MARKET

NNVC

NNVC

Nanoviricides
AMEX
1.330
-0.040
-2.92%
After Hours: 1.400 +0.07 +5.26% 17:11 05/01 EDT
OPEN
1.400
PREV CLOSE
1.370
HIGH
1.400
LOW
1.301
VOLUME
82.46K
TURNOVER
--
52 WEEK HIGH
3.590
52 WEEK LOW
0.9400
MARKET CAP
20.80M
P/E (TTM)
-1.8550
1D
5D
1M
3M
1Y
5Y
1D
Biotech Alert: Searches spiking for these stocks today
TipRanks · 3d ago
Weekly Report: what happened at NNVC last week (0421-0425)?
Weekly Report · 3d ago
Weekly Report: what happened at NNVC last week (0414-0418)?
Weekly Report · 04/21 12:17
Weekly Report: what happened at NNVC last week (0407-0411)?
Weekly Report · 04/14 12:02
NanoViricides Evaluates Drug NV-387 for Measles Treatment, Targets Virus Spread with New Antiviral Approach
Benzinga · 04/14 10:34
Weekly Report: what happened at NNVC last week (0331-0404)?
Weekly Report · 04/07 12:02
Weekly Report: what happened at NNVC last week (0324-0328)?
Weekly Report · 03/31 12:18
Weekly Report: what happened at NNVC last week (0317-0321)?
Weekly Report · 03/24 12:01
More
About NNVC
More
NanoViricides, Inc. is a clinical-stage company that is creating special purpose nanomaterials for antiviral therapy. Its nanoviricide class of drug candidates and the nanoviricide technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. Its lead drug candidate is NV-387, a broad-spectrum antiviral drug that it plans to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. It is focused on advancing NV-387 into Phase II human clinical trials. Its other advanced drug candidate is NV-HHV-1 for the treatment of Shingles. NV-CoV-2 (API NV-387) is its nanoviricide drug candidate for COVID-19 that does not encapsulate remdesivir. NV-CoV-2-R is its other drug candidate for COVID-19 that is made up of NV-387 with remdesivir encapsulated within its polymeric micelles. It has developed both of its own drug candidates NV-CoV-2 and NV-CoV-2-R independently.
Recently
Symbol
Price
%Change
    T
  • 27.64
  • -0.22%

Webull offers NanoViricides Inc stock information, including AMEX: NNVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NNVC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NNVC stock methods without spending real money on the virtual paper trading platform.